Abstract:The identification of tumor related membrane protein is important for both cancer diagnosis and targeted therapy. Currently, the number of ideal clinical biomarkers is still limited partially because of lacking efficient methods in biomarker discovery. Targeting peptides are generated by library screening and can recognize their cognate targets with high specificity and affinity. In addition, these functional peptides have been considered to be a valuable molecule for both imaging detection and targeting therapy in oncology. The selected peptides can be used to identify cell-surface protein biomarkers of cancer cells. In our study, the peptide (VECYLIRDNLCIY) derived from the bacteria displaying library worked as a bait to capture its binding partner and aldolase A was identified as the candidate. The results indicated that aldolase A' expression level on the cell membrane was regulated by PI3K and aldolase A located on the membrane could inhibit the aggression of tumors through mediating cell metabolic pathway. Aldolase A could work as the joint for the metabolic and signal pathways related to tumor progression. In our work, we demonstrated a promising technology for selecting and identifying binding partners for cell-specific peptides that enables discovery of new tumor biomarkers, showing great scientific study values and clinical translation potencies. SIGNIFICANCE: MS-based cancer biomarker discovery provides promising target candidates for cancer diagnosis and therapy. However, the inevitable limits make it inconvenient in the process of sample preparation and data analysis. In this way, the small molecular probes show some advantages due to their readily availability and specific binding affinity such as the aptamers screened with SELEX technology and peptides derived from displaying libraries. In the present study, aldolase A was proved to be the membrane binding partner of a specific peptidic ligand towards ZR-75-1 tumor cell. It was discovered that membrane aldolase A was more sensitive and observable than other subcellular fractions in response to cellular metabolic state alteration or glucose availability. In addition, the reduced membrane-localized aldolase A expression indicated a more aggressive tumor phenotype and was accompanied by the upregulation of MMP-2/MMP-9. The non-glycolysis activity endowed it with potential utility as a tumor diagnostic marker and therapeutic target. This work demonstrates the practicability of screened peptide in cancer biomarker discovery, facilitating the development of diagnostic tools and therapeutic approaches to cancer, and markedly improves our understanding of cancer biology.

Preparation and characterization of a biomimetic honeycomb cross-linked chitosan membrane and its application in the serum of gastric cancer patients

Bi-amino acid functionalized biomimetic honeycomb chitosan membrane as a multifunctional hydrophilic probe for specific capture of N-linked glycopeptides in nasopharyngeal carcinoma's disease patient's serum

Anti-melanoma Effect and Action Mechanism of a Novel Chitosan-Based Composite Hydrogel Containing Hydroxyapatite Nanoparticles

Hydrophilic materials based on hydrogel polymers for enrichment of glycopeptides from serum of colorectal cancer patients

Post-synthesis of Biomimetic Chitosan with Honeycomb-Like Structure for Sensitive Recognition of Phosphorylated Peptides.

Application of Microscopic Highly Hydrophilic Silica-Based Nanocomposites with High Surface Exposure in the Efficient Identification of Intact N-Glycopeptides

One-step fabrication of dipeptide-based bifunctional polymer for individual enrichment of glycopeptides and phosphopeptides from serum

Synthesis and Characterization of a Novel Boronic Acid-Functionalized Chitosan Polymeric Nanosphere for Highly Specific Enrichment of Glycopeptides.

A novel chitosan hydrogel membrane by an improved electrophoretic deposition and its characteristics in vitro and in vivo

Rationally-designed Chitosan-based Polymeric Nanomaterials According to Intrinsic Characteristics for Cancer Therapy and Theranostics: A Review.

Profiling of Endogenous Serum Phosphorylated Peptides by Titanium (IV) Immobilized Mesoporous Silica Particles Enrichment and MALDI-TOFMS Detection

Hydroxyethyl Chitosan Hydrogels for Enhancing Breast Cancer Cell Tumorigenesis.

Small molecules as potential biomarkers of early gastric cancer: A mass spectrometry imaging approach

An explore method for quick screening biomarkers based on effective enrichment capacity and data mining

Copper-Chelated Chitosan Microgels for the Selective Enrichment of Small Cationic Peptides

An Anti-Bacterial and Anti-Cancer Fibrous Membrane with Multiple Therapeutic Effects for Prevention of Pancreatic Cancer Recurrence

Unlocking the Potential of Chitosan in Immunoassay Sensor

Identification of Cancer Protein Biomarker Based on Cell Specific Peptide and Its Potential Role in Predicting Tumor Metastasis.

Selective uptake of chitosan polymeric micelles by circulating monocytes for enhanced tumor targeting

Construction of Aptamer‐siRNA Chimera/PEI/5‐FU/Carbon Nanotube/Collagen Membranes for the Treatment of Peritoneal Dissemination of Drug‐Resistant Gastric Cancer

Facile Preparation of Titanium Functionalized Cross-Linked Chitosan Polymer for Phosphoproteome Analysis in Serum